Whether the development of secondary malignancies at these sites is exclusively mediated by cancer-induced hypercalcemia via CaSR signaling or includes other complications such as CaSR-mediated stimulation of inflammation and/or tumor immune suppression remains to be fully elucidated. This evidence concerns the gene CASR and neoplasm.